LEADER 01542nas  2200517-a 450 
001 9910168760303321
005 20240807213014.0
011   $a2046-8962
035   $a(CKB)3150000000001036
035   $a(CONSER)--2013243013
035   $a(EXLCZ)993150000000001036
100   $a20110401a20129999  ---         a
101 0 $aeng
135   $aur|||||||||||
181   $ctxt$2rdacontent
182   $cc$2rdamedia
183   $acr$2rdacarrier
200 00$aPharmaceutical patent analyst
210   $aLondon $cFuture Science$d2012-
210 31$a[Milton Park, Oxfordshire] :$cTaylor & Francis
215   $a1 online resource
300   $aRefereed/Peer-reviewed
311 08$aPrint version: Pharmaceutical patent analyst. 2046-8954 (DLC)  2013243013 (OCoLC)784547864 
531   $aPHARM PAT ANAL
531 0 $aPharm. pat. anal.
606   $aDrugs$vPatents$vPeriodicals
606   $aDrug development$vPeriodicals
606   $aPatents as Topic
606   $aDrug Industry
606   $aDrug development$2fast$3(OCoLC)fst00898670
606   $aDrugs$2fast$3(OCoLC)fst00898761
608   $aPeriodical.
608   $aPatents.$2fast
608   $aPeriodicals.$2fast
615  0$aDrugs
615  0$aDrug development
615 12$aPatents as Topic.
615 22$aDrug Industry.
615  7$aDrug development.
615  7$aDrugs.
676   $a615.1
906   $aJOURNAL
912   $a9910168760303321
920   $aexl_impl conversion
996   $aPharmaceutical patent analyst$92129154
997   $aUNINA